Recent clinical findings on the role of kinase inhibitors in COVID-19 management

Recent clinical findings on the role of kinase inhibitors in COVID-19 management


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: امیر باغبانزاده , آیلار نخلبند , بهزاد برادران , سودا جعفری , یاسین باقری , سهیلا منتظرصاحب , راحله فرحزادی

کلمات کلیدی: Kinase inhibitor COVID-19 Signaling JAK/STAT BTK p38 MAPK GSK-3 CR

نشریه: 0 , 2022 , 306 , 2022

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله راحله فرحزادی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات هماتولوژی و انکولوژی
کد مقاله 79212
عنوان فارسی مقاله Recent clinical findings on the role of kinase inhibitors in COVID-19 management
عنوان لاتین مقاله Recent clinical findings on the role of kinase inhibitors in COVID-19 management
ناشر 9
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق) Life Sciences
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

The highly pathogenic, novel coronavirus disease (COVID-19) outbreak has emerged as a once-in-a-century pandemic with poor consequences, urgently calling for new therapeutics, cures, and supportive interventions. It has already affected over 250 million people worldwide; thereby, there is a need for novel therapies to alleviate the related complications. There is a paradigm shift in developing drugs and clinical practices to combat COVID- 19. Several clinical trials have been performed or are testing diverse pharmacological interventions to alleviate viral load and complications such as cytokine release storm (CRS). Kinase-inhibitors have appeared as potential antiviral agents for COVID-19 patients due to their effcacy against CRS. Combination of kinase inhibitors with other therapies can achieve more effcacy against COVID-19. Based on the pre-clinical trials, kinase inhibitors such as Janus kinase-signal transducer and activator of transcription (JAK/STAT) inhibitors, Brutton's tyrosin kinase (BTK) inhibitors, p38 mitogen-activated protein kinases (p38 MAPK) inhibitors, Glycogen synthase kinase 3 (GSK-3) inhibitors can be a promising strategy against COVID-19. Kinase inhibitors possess crucial pharmacological properties for a successful re-purposing in terms of dual anti-inflammatory and anti-viral effects. This review will address the current clinical evidence and the newest discovery regarding the application of kinase inhibitors in COVID-19. An outlook on ongoing clinical trials (clinicaltrials.gov) and unpublished data is also presented here. Besides, Kinase inhibitors' function on COVID-19-mediated CRS is discussed.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
امیر باغبانزادهدوم
آیلار نخلبندسوم
بهزاد برادرانچهارم
سودا جعفریپنجم
یاسین باقریششم
سهیلا منتظرصاحبهشتم
راحله فرحزادینهم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Covid Life Science.pdf1401/05/052048514دانلود